Revenue rose 21% to $216.1mln in the year to 31 December 2016 from $178.2mln a year earlier, as a 43% increase in commercial platform revenue offset a 32% decline in innovation platform revenue.
The commercial platform business was boosted by its consolidated joint venture Hutchison Whampoa Sinopharm Pharmaceuticals Company Ltd in Shanghai, which supplies prescription drugs.
Net income increased 46% to $11.7mln from $8.0mln, even as research and development expenses rose to $76.1mln from $55.8mln.
During the period, the company said it had accelerated and expanded work on c-MET inhibitor candidate savolitinib through an amended license deal with AstraZeneca (LON:AZN) that covers a Phase III global trial for treatment of kidney, lung and gastric cancers.
Under the amended deal with AstraZeneca in August, Chi-Med agreed to provide up to $50mln for the joint-development costs of savolitinib in return for a five percentage point increase in royalties payable on the drug’s sales across indications in all markets outside of China.
The company reported positive results from the phase III study of fruquintinib for the treatment of colorectal cancer and expects to launch the product in 2018.
Hutchison is also conducting phase I studies on multiple novel drug candidates including HMPL-523 against spleen tyrosine kinase and HMPL-453 against fibroblast growth factor receptors.
At the end of the year the group held cash resources of $173.7mln, compared to $38.8mln the prior year, which Hutchison believes is sufficient to fund its activities, including the increased cash requirements following the amendment to the savolitinib collaboration with AstraZeneca.
Shares rose 3.54% to 2,498p in morning trading.
Story by ProactiveInvestors
Trump Feel Good Financial Narrative Crumbling - Greg Hunter, Craig Hemke Video
Trump Gives Mexico Extraordinary Refugee Surprise
X22Report Central Bankers Tricks Are Now Being Used Against Them to Bring the Economy Down - Episode 1263a
The End of YouTube: The Apocalypse With "We Are Change" _Tim Pool
Three Events Collide On April 26th—Two Drills and An Emergency Trump Meeting—What’s Up?
Ryan, McConnell to Trump: "You f***ed Up, You Trusted Us"
103,000 Entitled Muslims in Michigan Just Woke up to Nasty Surprise From Pissed Off Citizens
U.S. Air Force to Launch Unarmed ICBM Off California Coast Tonight in Preparation for Striking North Korea
FBI Reopens Hillary Clinton Investigation
This Could Save Your Job, House and Children - Emergency Call to Action
Next One Out? Sean Hannity Under Attack as Fox News Continues its War Against Conservatives
Why Earth’s Winds are Changing with Tornadoes, Waterspouts & Plasma Lightning Intensifying
Elite Rituals You Need To Know, Child Drag Queen Hour & Giraffe Baby Live
BART Takeover Robbery: 40 to 60 Teens Swarm Train, Rob Weekend Riders
Iran's Nuclear Weapons Program: On Course, Underground, Uninspected
An Angry Canada Responds To Trump’s Lumber Tariff… And What It Means For The Economy
“Mother Earth will swallow you, lay your body down”
North Korea stages massive artillery drill. US nuclear sub docks in South
As Their 70th Anniversary Of Being Regathered Approaches, Is The LORD Preparing To Visit Israel?
UFO - Corpuscular Ship..24.April.2017 (Video)
Chilling Ghost Apparition Caught on Tape
Curcumin outperforms anti-inflammatory drug for rheumatoid arthritis relief
The 3 Best Major OOC Sports Moments of last 5 years for Florida State, Boston College, and Notre Dame
It’s Trump That Has the Real “PizzaGate” Problem
Tuesday Night Acoustic Guitar Excellence: Trevor Gordon Hall, "Midnight and Raining"
French Mayor Fined for ‘Too Many Muslim Children’ Comment
What Angels Need
Group of Gorillas Approach Man in Ugandan Forest
Trump Comparisons to Ronald Reagan Aren’t Always a Good Thing